NetworkNewsBreaks – Zogenix Inc. (NASDAQ: ZGNX) Featured in Mizuho Securities Research Report
Zogenix Inc. (NASDAQ: ZGNX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Zogenix hosted a KOL event on 4/22. The most important data point in our view was the updated long-term data from FINTEPLA in Dravet syndrome, which reinforces the strong profile of FINTEPLA in this indication and the potential for the drug to become standard of care. Clinical data in a new indication (Sunflower syndrome) was also presented, with early signal observed in a handful of patients. However, we believe more clinical data will be needed before this indication can…







